Literature DB >> 31755398

Oral Modified Drug Release Solid Dosage Form with Special Reference to Design; An Overview.

Senthilkumar Murugesan1, Byran Gowramma1, Kaviarasan Lakshmanan1, Veera Venkata Satyanarayana Reddy Karri2, Arun Radhakrishnan2.   

Abstract

Oral drug delivery is the most widely utilized route of administration among all the routes that have been explored for systemic delivery of drugs via pharmaceutical products of different dosage form and this oral route provides maximum active surface area among all drug delivery system for administration of various drugs. The attractiveness of these dosage forms is due to awareness of toxicity and ineffectiveness of drugs when administered by oral conventional method in the form of tablets and capsules. Usually, conventional dosage form produces wide range of fluctuation in drug concentration in the bloodstream and tissues with consequent undesirable toxicity and poor efficiency. The maintenance of concentration of drug in plasma within therapeutic index is very critical for effective treatment. These factors as well as factors such as repetitive dosing and unpredictable absorption lead to the concept of oral modified drug delivery systems like Sustained release, prolonged release, modified release, extended release. These formulations are used to identify drug delivery systems that are designed to achieve or extend therapeutic effect by continuously releasing medication over an extended period of time after administration of a single dose. This review describes the basic information regarding modified release dosage form like designed to release their medication in controlled manner, criteria for selecting modified release dosage form and factors influencing the dosage and release pattern. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Keywords:  Oral drug delivery; capsules; conventional dosage form; oral modified drug delivery systems; plasma; therapeutic index; toxicity.

Year:  2020        PMID: 31755398     DOI: 10.2174/2589977511666191121094520

Source DB:  PubMed          Journal:  Curr Drug Res Rev        ISSN: 2589-9775


  2 in total

1.  Development and implementation of SafeMedWaste, a chemical denaturant for non-hazardous disposal of controlled medications.

Authors:  Emma Leishman; Yizhong Wang; Reddy Channu; Evan Boyst; Marshall Hartmann; Justin Stas
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

2.  Influence of Prunus domestica gum on the release profiles of propranolol HCl floating tablets.

Authors:  Salman Mehmood; Syed Muhammad Farid Hasan; Rabia Noor; Muhammad Sikandar; Syed Nadeem Ul Hasan Mohani; Fauzia Israr; Syed Imran Ali; Majeed Ullah; Fouzia Hassan
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.